Tissue Repair and Cellular Regeneration BPC-157, a stable gastric pentadecapeptide, has been shown in animal studies to accelerate healing in muscle, tendon, and nerve tissue by enhancing angiogenesis and modulating growth factor expression
The most extensively documented mechanism involves upregulation of vascular endothelial growth factor, known as VEGF, and the broader angiogenic program
Rather than full cessation, some clinicians discuss the option of maintenance dosing, using a lower dose or less frequent injection schedule to sustain appetite regulation at a reduced cost or with fewer side effects
If practitioners stay dedicated to constant education and responsible practice, they will be excited about more focused therapies, fewer side effects, and improved patient results
PMID: 23755725 Secondary VEGF / VEGFR2 Signaling VEGF-Mediated Angiogenesis Pathway Research has demonstrated that BPC-157 upregulates VEGFR2 expression in endothelial cell models
Reviewed by FDA against compounding inclusion in December 2024
